- Home
- FLOC vs DNLI Comparison
FLOC vs DNLI Comparison
Compare FLOC & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLOC | DNLI |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 473.4M | 2.5B |
| IPO Year | 2025 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FLOC | DNLI |
|---|---|---|
| Price | $18.67 | $18.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 14 |
| Target Price | $30.17 | ★ $32.58 |
| AVG Volume (30 Days) | 330.4K | ★ 1.7M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $748,499,000.00 | N/A |
| Revenue This Year | $43.28 | N/A |
| Revenue Next Year | $7.88 | $3,993.60 |
| P/E Ratio | $13.77 | ★ N/A |
| Revenue Growth | ★ 76.22 | N/A |
| 52 Week Low | $14.03 | $10.57 |
| 52 Week High | $30.50 | $24.35 |
Technical Indicators
Market Signals| Indicator | FLOC | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 65.21 | 51.69 |
| Support Level | $17.75 | $17.20 |
| Resistance Level | $19.10 | $20.61 |
| Average True Range (ATR) | 0.74 | 1.03 |
| MACD | 0.15 | -0.21 |
| Stochastic Oscillator | 81.88 | 29.72 |
Price Performance
Historical ComparisonAbout FLOC Flowco Holdings Inc.
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.